Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.prnewswire.com/news-releases/first-patient-treated-in-the-us-based-prostate-cancer-imaging-trial-of-cu-64-sar-bispsma-301529729.html
Apr 21, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next